182 related articles for article (PubMed ID: 38599378)
1. Roles and therapeutic targeting of ceramide metabolism in cancer.
Wajapeyee N; Beamon TC; Gupta R
Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
[TBL] [Abstract][Full Text] [Related]
2. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
3. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
4. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
5. Targeting the ceramide system in cancer.
Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
[TBL] [Abstract][Full Text] [Related]
6. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
7. Ceramide glycosylation and related enzymes in cancer signaling and therapy.
Li Z; Zhang L; Liu D; Wang C
Biomed Pharmacother; 2021 Jul; 139():111565. PubMed ID: 33887691
[TBL] [Abstract][Full Text] [Related]
8. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
10. Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.
García-González V; Díaz-Villanueva JF; Galindo-Hernández O; Martínez-Navarro I; Hurtado-Ureta G; Pérez-Arias AA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149660
[TBL] [Abstract][Full Text] [Related]
11. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
12. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
Dagan A; Wang C; Fibach E; Gatt S
Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
[TBL] [Abstract][Full Text] [Related]
13. Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.
Li F; Zhang N
Curr Drug Metab; 2015; 17(1):37-51. PubMed ID: 26526831
[TBL] [Abstract][Full Text] [Related]
14. A review of ceramide analogs as potential anticancer agents.
Liu J; Beckman BS; Foroozesh M
Future Med Chem; 2013 Aug; 5(12):1405-21. PubMed ID: 23919551
[TBL] [Abstract][Full Text] [Related]
15. Ceramide in apoptotic signaling and anticancer therapy.
Lin CF; Chen CL; Lin YS
Curr Med Chem; 2006; 13(14):1609-16. PubMed ID: 16787207
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of ceramide in cancer treatment.
Moro K; Nagahashi M; Gabriel E; Takabe K; Wakai T
Breast Cancer; 2019 Jul; 26(4):407-415. PubMed ID: 30963461
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
19. Ceramide-based therapeutics for the treatment of cancer.
Barth BM; Cabot MC; Kester M
Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
